Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/539997 stock hub

BOM/539997 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/539997is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.2B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/539997

In the news

Latest news · BOM/539997

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E32.2

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/539997 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

INR

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	997
Employees Change	191%
Employees Change Percent	23.7
Enterprise value	INR 18.9B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 18.2B
Price	INR 1,751
Price currency	INR
Rev Per Employee	4,630,352.06x
Sic	2834
Symbol	bom/539997
Website	https://www.kwalitypharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.11%
EV Earnings	33.46x
EV/EBIT	21.49x
EV/EBITDA	17.95x
EV/Sales	4.1x
P/B ratio	6.3x
P/E ratio	32.18x
P/S ratio	3.94x
PE Ratio10 Y	12.76x
PE Ratio3 Y	24.04x
PE Ratio5 Y	17.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.07%
EBITDA Margin	22.83%
Gross margin	48.39%
Gross Profit	INR 2.2B
Gross Profit Growth	28.42%
Gross Profit Growth Q	40.86%
Gross Profit Growth3 Y	18.06%
Gross Profit Growth5 Y	23.09%
Net Income	INR 565.3M
Net Income Growth	89.69%
Net Income Growth Q	87.69%
Net Income Growth3 Y	15.29%
Net Income Growth5 Y	34.01%
Pretax Margin	16.66%
Profit Margin	12.25%
Profit Per Employee	INR 567,043
Roa5y	15.2
Roe5y	33.26
ROIC	17.73
Roic5y	27.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	139.53%
Cagr3y	73.56%
Cagr5y	75.52%
EPS Growth	88.25
EPS Growth Q	87.94
EPS Growth3 Y	15.59
EPS Growth5 Y	33.98
Revenue Growth	33.23x
Revenue Growth Q	46.24x
Revenue Growth3 Y	23.02x
Revenue Growth5 Y	15.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 340.5M
Debt	INR 1.1B
Debt EBITDA	INR 1.05
Debt Equity	INR 0.38
Equity	INR 2.9B
Interest Coverage	8.32
Net Cash	INR -763.9M
Net Cash By Market Cap	INR -4.2
Net Debt EBITDA	INR 0.72
Net Debt Equity	INR 0.26
Tangible Book Value	INR 2.9B
Tangible Book Value Per Share	INR 278
WACC	5.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.77%
Dividend per share	INR 0
Last Dividend	INR 0.3

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	139.38%
200-day SMA	1,154
3Y total return	423.04%
50-day SMA	1,545.7
50-day SMA vs 200-day SMA	50over200
5Y total return	1,565.34%
All Time High	1,782
All Time High Change	-3.74%
All Time High Date	2026-04-20
All Time Low	20.43
All Time Low Change	8,298.04%
All Time Low Date	2016-07-21
ATR	94.15
Beta	0.14
Beta1y	1.14
Beta2y	0.54
Ch YTD	54.76
High	1,757.4
High52	1,782
High52 Date	2026-04-20
High52ch	-1.73%
Low	1,717.1
Low52	695
Low52 Date	2025-05-09
Low52ch	151.98%
Ma50ch	10.98%
Price vs 200-day SMA	48.63%
RSI	63.52
RSI Monthly	70.37
RSI Weekly	67.63
Sharpe ratio	1.85x
Sortino ratio	3.56
Total Return	-0.77%
Tr YTD	54.76
Tr1m	14.45%
Tr1w	3.52%
Tr3m	48.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 880.4M
Operating Income Growth	50.59
Operating Income Growth Q	88.73
Operating Income Growth3 Y	18.46
Operating Income Growth5 Y	33.82
Operating margin	19.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,303,669%
Shares Insiders	76.83%
Shares Institutions	0%
Shares Out	10,376,198
Shares Qo Q	-0.04%
Shares Yo Y	0.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	17,530.85x
Bv Per Share	279.5
Ch1m	14.45
Ch1w	3.52
Ch1y	139.4
Ch3m	48.17
Ch3y	423
Ch5y	1,565.3
Ch6m	99.62
Change	2.1%
Change From Open	1.46
Close	1,715.3
Days Gap	0.63
Depreciation Amortization	173,377,000
Dollar Volume	4,469,190
Earnings Date	2026-05-19
EBIT	INR 880.4M
EBITDA	INR 1.1B
EPS	INR 54.42
F Score	1
Fiscal Year End	March
Founded	1,983
Graham Number	585.0012
Graham Upside	-66.6
Income Tax	INR 203.8M
Is Primary Listing	1
Last Earnings Date	2026-02-02
Last Report Date	2025-12-31
Last Split Date	2017-10-11
Last Split Type	Forward
Lynch Fair Value	INR 1,360
Lynch Upside	-22.32
Ma150	1,190.2
Ma150ch	44.11%
Ma20	1,630.9
Ma20ch	5.17%
Next Earnings Date	2026-05-19
Open	1,726.1
Position In Range	84.86
Price Date	2026-05-08
Price EBITDA	INR 17.24
Ptbv Ratio	6.3
Relative Volume	0.15x
Revenue	4,616,461,000x
Tax By Revenue	4.42x
Tax Rate	26.51%
Tr6m	99.62%
Volume	2,552

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/539997 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/539997 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/539997?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+76.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

BOM/539997 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.5

Neutral momentum band

Price vs 200-day MA

+48.6%

50/200-day relationship not available

Beta (5Y)

0.14

Less volatile than the market

Sharpe ratio

1.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/539997

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/539997 stock rating?

bom/539997 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/539997 analysis?

The full report lives at /stocks/bom/539997/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/539997?

The latest report frames bom/539997 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/539997 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.